← Leaderboards
Shumei Song
University Of Tx Md Anderson Can Ctr
$2,178,114
Attributed
$2,178,114
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $884.2K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,178,114 · 1
By mechanism
R01$2,178,114 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Anil K Sood$29,572,737
- Russell R Broaddus$6,374,452
- George A. Calin$5,774,539
- Jinsong Liu$2,476,553
- Vahid Afshar-Kharghan$3,543,397
Others in their field
Other Rising Stars on “Genetically Engineered Mouse”
- Sarah Elizabeth Lutz · University Of Illinois At Chicago$3,911,564
- Xu Chen · University Of California, San Francisco$3,581,285
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Torben Schiffner · Vanderbilt University$3,383,634
- Jennifer Eileen Adair · Fred Hutchinson Cancer Center$3,353,845
- Leona Gagnon · Jackson Laboratory$2,792,098
Research focus
Genetically Engineered MouseAscitesGastric AdenocarcinomaGeneticCarcinomatosisCd3 AntigensCd8-Positive T-LymphocytesAntibodiesAffectCellsCell TypeClinicClinical TrialsClone CellsCoculture TechniquesCollaborationsCell Culture TechniquesCrispr/Cas TechnologyCtla4 GeneCell ModelEffective TherapyFlow CytometryGalactose Binding LectinGrowth
Grant awards (4)
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma$884,176
R01 · FY2025 · CA · contact PI
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma$420,169
R01 · FY2024 · CA · contact PI
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma$452,423
R01 · FY2023 · CA · contact PI
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma$421,346
R01 · FY2022 · CA · contact PI